日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials

HLA-B27状态是否影响伊克珠单抗治疗中轴型脊柱关节炎的疗效？来自COAST-V、COAST-W和COAST-X试验的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00810-5
Reveille, John D; Rudwaleit, Martin; Rahman, Proton; Maldonado-Cocco, Jose A; Magrey, Marina; Bolce, Rebecca; Ng, Khai Jing; Gibble, Theresa Hunter; Lisse, Jeffrey; Park, So Young; Kronbergs, Andris; Navarro-Compán, Victoria
关节炎
发表日期：2026
文献求助 收藏

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

无论症状持续时间长短，伊克珠单抗都能改善中轴型脊柱关节炎患者的体征、症状和生活质量。

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03305-5
Navarro-Compán, Victoria; Reveille, John D; Rahman, Proton; Maldonado-Cocco, José A; Magrey, Marina; Bolce, Rebecca; Panni, Tommaso; Kronbergs, Andris; Rudwaleit, Martin
关节炎
发表日期：2025
文献求助 收藏

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

早期临床反应与放射学轴性脊柱关节炎患者接受ixekizumab治疗的长期疗效相关

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004429
Ramiro, Sofia; Lukas, Cédric; Bessette, Louis; Wickersham, Pendleton; Panni, Tommaso; Bolce, Rebecca; Liu-Leage, Soyi; Janos, Boris; Nissen, Michael J; Wei, James Cheng-Chung
关节炎
发表日期：2024
文献求助 收藏

Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis

银屑病关节炎中远端指间关节滑膜-肌腱复合体临床成分与伊克珠单抗或阿达木单抗治疗反应的相关性

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keae060
McGonagle, Dennis; Kavanaugh, Arthur; McInnes, Iain B; Kristensen, Lars Erik; Merola, Joseph F; Strober, Bruce; Bolce, Rebecca; Lisse, Jeffrey; Pustizzi, Jennifer; Sapin, Christophe; Ritchlin, Christopher
关节炎
银屑病
发表日期：2024
文献求助 收藏

Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab

对新型无柠檬酸盐伊克珠单抗制剂注射体验的满意度

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02812-1
Chabra, Sanjay; Birt, Julie; Bolce, Rebecca; Lisse, Jeffrey; Malatestinic, William N; Zhu, Baojin; Kimel, Miriam; McCormack, Julie; Stefan, Marissa; Cragun, W Chad
发表日期：2024
文献求助 收藏

Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial

基于炎症客观指标探讨伊克珠单抗对强直性脊柱炎患者疼痛的影响：一项大型随机临床试验的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00660-7
de Vlam, Kurt; Maksymowych, Walter P; Gallo, Gaia; Rahman, Proton; Mease, Philip; Krishnan, Venkatesh; McVeigh, Conor J; Lisse, Jeffrey; Zhu, Danting; Bolce, Rebecca J; Conaghan, Philip G
炎症
炎症/感染
Immunology/Inflammation
强直性脊柱炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial

更正：基于炎症客观指标探索伊克珠单抗对强直性脊柱炎患者疼痛的影响：一项大型随机临床试验的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00686-x
de Vlam, Kurt; Maksymowych, Walter P; Gallo, Gaia; Rahman, Proton; Mease, Philip; Krishnan, Venkatesh; McVeigh, Conor J; Lisse, Jeffrey; Zhu, Danting; Bolce, Rebecca J; Conaghan, Philip G
炎症
炎症/感染
Immunology/Inflammation
强直性脊柱炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study

轴性脊柱关节炎患者停用ixekizumab治疗后的再捕获率和再治疗率：一项随机安慰剂对照停药研究的第104周结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2022-222731
Landewé, Robert B M; Poddubnyy, Denis; Rahman, Proton; Van den Bosch, Filip E; Bolce, Rebecca; Liu Leage, Soyi; Lisse, Jeffrey R; Park, So Young; Gensler, Lianne
关节炎
发表日期：2023
文献求助 收藏

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2

两项 III 期临床试验（SPIRIT-P1 和 SPIRIT-P2）表明，ixekizumab 对银屑病关节炎患者的中轴症状有影响。

期刊:Therapeutic Advances in Musculoskeletal Disease
影响因子:4.1
doi:10.1177/1759720X231189005
Deodhar, Atul; Gladman, Dafna; Bolce, Rebecca; Sandoval, David; Park, So Young; Leage, Soyi Liu; Nash, Peter; Poddubnyy, Denis
关节炎
银屑病
发表日期：2023
文献求助 收藏

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

一项针对中重度银屑病和银屑病关节炎的临床试验中，对伊克珠单抗治疗指甲银屑病的疗效进行全面综述

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00553-1
Kirkham, Bruce W; Egeberg, Alexander; Behrens, Frank; Pinter, Andreas; Merola, Joseph F; Holzkämper, Thorsten; Gallo, Gaia; Ng, Khai Jing; Bolce, Rebecca; Schuster, Christopher; Nash, Peter; Puig, Luis
关节炎
银屑病
发表日期：2023
文献求助 收藏